Clinical Trial Details
EORTC-30863
Back to Clinical Trials Database
Phase III prospective randomized trial for the study of TUR + a single intravesical instillation of Epirubicin versus TUR alone in single, primary or recurrent, Ta/T1 papillary carcinoma of the bladder.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 15-Sep-1986 Date Step1 close: 15-Sep-1989 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 212 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
